A prognostic study of patient who completed Study 0761-003; a randomized late phase II study of VCAP/AMP/VECP (mLSG15) and mLSG15+KW-0761 in patients with CCR4-positive adult T-Cell leukemia-lymphoma (untreated primary disease)
Not Applicable
- Conditions
- Adult T-cell leukemia-lymphoma
- Registration Number
- JPRN-UMIN000013294
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Refer to the article
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-free survival Overall survival
- Secondary Outcome Measures
Name Time Method